Results of First CD34+ Mixed Chimerism Analysis
The study coordinator e-mailed me today and said the results first CD34+ Mixed Chimerism Analysis were well above 90% which means I don't start the lenalidomide. They will test it again in 30 day and if I am still above 90%, I will be off the study.
Data
__________________
Prostate Cancer: Treated in early 2013 with HDR Brachytherapy. MDS-RCMD: Oct 2014. Biopsies: 46,XY,t(7;18)[2]: 46,XY,del(7)( q22)[3]: 45,XY,-7[6]: 45,XY,-7[10]: 45,XY,-7[13]. HSCT in April 2016.
|